Education
About Us
Working with TipRanks
Follow Us
Decoy Therapeutics (DCOY)
NASDAQ:DCOY
DCOY Stock Chart & Stats
$0.66
-$0.06(-3.48%)
At close: 4:00 PM EST
$0.66
-$0.06(-3.48%)
Day’s Range― - ―
52-Week Range$0.51 - $49.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)356.88K
Market Cap
$5.81M
Enterprise Value-$3.04M
Total Cash (Recent Filing)$4.81M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Mar 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.77
Shares Outstanding6,384,177
10 Day Avg. Volume434,140
30 Day Avg. Volume356,875
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.18
Price to Sales (P/S)0.00
P/FCF Ratio-0.39
Enterprise Value/Market Cap-0.52
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.75K
Enterprise Value/Ebitda0.60
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DCOY FAQ
What was Decoy Therapeutics’s price range in the past 12 months?
Decoy Therapeutics lowest stock price was $0.51 and its highest was $49.50 in the past 12 months.
What is Decoy Therapeutics’s market cap?
Decoy Therapeutics’s market cap is $5.81M.
When is Decoy Therapeutics’s upcoming earnings report date?
Decoy Therapeutics’s upcoming earnings report date is Mar 30, 2026 which is in 70 days.
How were Decoy Therapeutics’s earnings last quarter?
Currently, no data Available
Is Decoy Therapeutics overvalued?
According to Wall Street analysts Decoy Therapeutics’s price is currently Overvalued.
Does Decoy Therapeutics pay dividends?
Decoy Therapeutics does not currently pay dividends.
What is Decoy Therapeutics’s EPS estimate?
Decoy Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Decoy Therapeutics have?
Decoy Therapeutics has 6,384,177 shares outstanding.
What happened to Decoy Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Decoy Therapeutics?
Currently, no hedge funds are holding shares in DCOY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Decoy Therapeutics
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.
Technical Analysis
Biodexa Pharmaceuticals
―
Q/C Technologies
―
Scinai Immunotherapeutics
―
Oragenics
―
Onconetix
―
Ownership Overview
0.39% Insiders
0.02% Mutual Funds
<0.01% Other Institutional Investors
99.58% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---